Company intelligence / Profile preview

Probably Genetic

San Francisco, California, United Statesprobablygenetic.com ↗

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

Probably Genetic operates a commercial patient intelligence platform that uses machine learning and at-home DNA testing to identify undiagnosed patients with rare genetic diseases. The company has enabled over 100,000 individuals to access free or low-cost diagnostic services and connects them with resources such as counseling, advocacy groups, and clinical trials. Their approach has helped diagnose more than half of previously unexplained cases among their users.

Therapeutic areas: Rare DiseasesNeurology
Modalities: Diagnostic test (Genetic testing)At-home genetic testing kitData platform (for patient identification and engagement)
Industry: Molecular Diagnostics

Partnerships

Over 50 patient advocacy organizations including The Bluefield Project to Cure FTD

Beyond the preview

Go deeper on Probably Genetic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probably Genetic.

Explore the full profile